Pediatric Rheumatology

unofficial impact factor 1.74

This article is part of the supplement: 15th Paediatric Rheumatology European Society (PreS) Congress

Open Access Email this article to a friend

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis

SO Salugina*, ES Fedorov, EN Alexandrova, AA Novikov, MV Cherkasova, AA Baranov, YA Valogina, TN Nikolaeva and NA Zubova

  • * Corresponding author: SO Salugina

Pediatric Rheumatology 2008, 6(Suppl 1):P9 doi:10.1186/1546-0096-6-S1-P9

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.